Literature DB >> 22365829

Epigenetic silencing of core histone genes by HERS in Drosophila.

Saya Ito1, Sally Fujiyama-Nakamura, Shuhei Kimura, Jinseon Lim, Yuki Kamoshida, Yumi Shiozaki-Sato, Shun Sawatsubashi, Eriko Suzuki, Masahiko Tanabe, Takashi Ueda, Takuya Murata, Hiromi Kato, Fumiaki Ohtake, Ryoji Fujiki, Tsuneharu Miki, Alexander Kouzmenko, Ken-Ichi Takeyama, Shigeaki Kato.   

Abstract

Cell cycle-dependent expression of canonical histone proteins enables newly synthesized DNA to be integrated into chromatin in replicating cells. However, the molecular basis of cell cycle-dependency in the switching of histone gene regulation remains to be uncovered. Here, we report the identification and biochemical characterization of a molecular switcher, HERS (histone gene-specific epigenetic repressor in late S phase), for nucleosomal core histone gene inactivation in Drosophila. HERS protein is phosphorylated by a cyclin-dependent kinase (Cdk) at the end of S-phase. Phosphorylated HERS binds to histone gene regulatory regions and anchors HP1 and Su(var)3-9 to induce chromatin inactivation through histone H3 lysine 9 methylation. These findings illustrate a salient molecular switch linking epigenetic gene silencing to cell cycle-dependent histone production. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365829     DOI: 10.1016/j.molcel.2011.12.029

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  12 in total

Review 1.  Point mutations in an epigenetic factor lead to multiple types of bone tumors: role of H3.3 histone variant in bone development and disease.

Authors:  Shigeaki Kato; Takeaki Ishii; Alexander Kouzmenko
Journal:  Bonekey Rep       Date:  2015-07-01

Review 2.  Coordinating cell cycle-regulated histone gene expression through assembly and function of the Histone Locus Body.

Authors:  Robert J Duronio; William F Marzluff
Journal:  RNA Biol       Date:  2017-01-06       Impact factor: 4.652

3.  dCas9-targeted locus-specific protein isolation method identifies histone gene regulators.

Authors:  Chiahao Tsui; Carla Inouye; Michaella Levy; Andrew Lu; Laurence Florens; Michael P Washburn; Robert Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

Review 4.  HP1a: a structural chromosomal protein regulating transcription.

Authors:  Joel C Eissenberg; Sarah C R Elgin
Journal:  Trends Genet       Date:  2014-02-17       Impact factor: 11.639

5.  DDB1 and CUL4 associated factor 11 (DCAF11) mediates degradation of Stem-loop binding protein at the end of S phase.

Authors:  Umidahan Djakbarova; William F Marzluff; M Murat Köseoğlu
Journal:  Cell Cycle       Date:  2016-06-02       Impact factor: 4.534

6.  MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.

Authors:  Chunyu Wang; Hongmiao Sun; Renlong Zou; Tingting Zhou; Shengli Wang; Shiying Sun; Changci Tong; Hao Luo; Yanshu Li; Zhenhua Li; Enhua Wang; Yuhua Chen; Liu Cao; Feng Li; Yue Zhao
Journal:  Nucleic Acids Res       Date:  2015-04-30       Impact factor: 16.971

7.  How the cell cycle impacts chromatin architecture and influences cell fate.

Authors:  Yiqin Ma; Kiriaki Kanakousaki; Laura Buttitta
Journal:  Front Genet       Date:  2015-02-03       Impact factor: 4.599

8.  CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.

Authors:  Saya Ito; Akihisa Ueno; Takashi Ueda; Hideo Nakagawa; Hidefumi Taniguchi; Naruhiro Kayukawa; Atsuko Fujihara-Iwata; Fumiya Hongo; Koji Okihara; Osamu Ukimura
Journal:  Oncotarget       Date:  2018-04-03

9.  Gene-specific transcriptional mechanisms at the histone gene cluster revealed by single-cell imaging.

Authors:  Benjamin Guglielmi; Natalie La Rochelle; Robert Tjian
Journal:  Mol Cell       Date:  2013-08-22       Impact factor: 17.970

10.  The composition and organization of Drosophila heterochromatin are heterogeneous and dynamic.

Authors:  Joel M Swenson; Serafin U Colmenares; Amy R Strom; Sylvain V Costes; Gary H Karpen
Journal:  Elife       Date:  2016-08-11       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.